BSPK
Price
$0.18
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
2.06M
OVATF
Price
$0.02
Change
-$0.02 (-50.00%)
Updated
Aug 26 closing price
Capitalization
1.28M
Interact to see
Advertisement

BSPK vs OVATF

Header iconBSPK vs OVATF Comparison
Open Charts BSPK vs OVATFBanner chart's image
Bespoke Extracts
Price$0.18
Change-$0.00 (-0.00%)
Volume$2.66K
Capitalization2.06M
Ovation Science
Price$0.02
Change-$0.02 (-50.00%)
Volume$500
Capitalization1.28M
BSPK vs OVATF Comparison Chart in %
Loading...
BSPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OVATF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSPK vs. OVATF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSPK is a Hold and OVATF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (BSPK: $0.19 vs. OVATF: $0.02)
Brand notoriety: BSPK and OVATF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: BSPK: 6% vs. OVATF: 6%
Market capitalization -- BSPK: $2.06M vs. OVATF: $1.28M
BSPK [@Pharmaceuticals: Generic] is valued at $2.06M. OVATF’s [@Pharmaceuticals: Generic] market capitalization is $1.28M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.93B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSPK’s FA Score shows that 0 FA rating(s) are green whileOVATF’s FA Score has 0 green FA rating(s).

  • BSPK’s FA Score: 0 green, 5 red.
  • OVATF’s FA Score: 0 green, 5 red.
According to our system of comparison, BSPK is a better buy in the long-term than OVATF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSPK’s TA Score shows that 5 TA indicator(s) are bullish while OVATF’s TA Score has 0 bullish TA indicator(s).

  • BSPK’s TA Score: 5 bullish, 4 bearish.
  • OVATF’s TA Score: 0 bullish, 2 bearish.
According to our system of comparison, BSPK is a better buy in the short-term than OVATF.

Price Growth

BSPK (@Pharmaceuticals: Generic) experienced а -5.08% price change this week, while OVATF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BSPK($2.06M) has a higher market cap than OVATF($1.28M). BSPK YTD gains are higher at: 204.276 vs. OVATF (-38.250). OVATF has higher annual earnings (EBITDA): -339.46K vs. BSPK (-1M). BSPK has more cash in the bank: 21.4K vs. OVATF (10.2K). OVATF has less debt than BSPK: OVATF (284K) vs BSPK (1.16M). BSPK has higher revenues than OVATF: BSPK (1.08M) vs OVATF (90.3K).
BSPKOVATFBSPK / OVATF
Capitalization2.06M1.28M162%
EBITDA-1M-339.46K296%
Gain YTD204.276-38.250-534%
P/E RatioN/AN/A-
Revenue1.08M90.3K1,196%
Total Cash21.4K10.2K210%
Total Debt1.16M284K408%
FUNDAMENTALS RATINGS
BSPK vs OVATF: Fundamental Ratings
BSPK
OVATF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3895
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8565

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OVATF's Valuation (62) in the null industry is somewhat better than the same rating for BSPK (96). This means that OVATF’s stock grew somewhat faster than BSPK’s over the last 12 months.

OVATF's Profit vs Risk Rating (100) in the null industry is in the same range as BSPK (100). This means that OVATF’s stock grew similarly to BSPK’s over the last 12 months.

OVATF's SMR Rating (100) in the null industry is in the same range as BSPK (100). This means that OVATF’s stock grew similarly to BSPK’s over the last 12 months.

BSPK's Price Growth Rating (38) in the null industry is somewhat better than the same rating for OVATF (95). This means that BSPK’s stock grew somewhat faster than OVATF’s over the last 12 months.

BSPK's P/E Growth Rating (100) in the null industry is in the same range as OVATF (100). This means that BSPK’s stock grew similarly to OVATF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSPKOVATF
RSI
ODDS (%)
Bearish Trend 4 days ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
85%
N/A
Momentum
ODDS (%)
Bullish Trend 4 days ago
86%
Bearish Trend 4 days ago
59%
MACD
ODDS (%)
Bullish Trend 4 days ago
78%
Bearish Trend 4 days ago
55%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
83%
Bullish Trend 4 days ago
46%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
83%
Bearish Trend 4 days ago
46%
Advances
ODDS (%)
Bullish Trend 14 days ago
80%
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
84%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
BSPK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OVATF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NAT3.270.04
+1.24%
Nordic American Tanker
CLAR3.660.03
+0.83%
Clarus Corp
EPIX0.23N/A
+0.56%
ESSA Pharma
TROW108.16-3.36
-3.01%
T Rowe Price Group
ASAN13.46-1.17
-8.00%
Asana

BSPK and

Correlation & Price change

A.I.dvisor tells us that BSPK and OVATF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BSPK and OVATF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSPK
1D Price
Change %
BSPK100%
-5.08%
OVATF - BSPK
21%
Poorly correlated
N/A
BKUH - BSPK
8%
Poorly correlated
N/A
AVCNF - BSPK
5%
Poorly correlated
+0.48%
CANN - BSPK
4%
Poorly correlated
-8.42%
CAIHF - BSPK
2%
Poorly correlated
N/A
More

OVATF and

Correlation & Price change

A.I.dvisor tells us that OVATF and KHTRF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OVATF and KHTRF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OVATF
1D Price
Change %
OVATF100%
N/A
KHTRF - OVATF
25%
Poorly correlated
N/A
KKPCF - OVATF
24%
Poorly correlated
N/A
BSPK - OVATF
20%
Poorly correlated
-5.08%
NPPNY - OVATF
9%
Poorly correlated
N/A
PCLOF - OVATF
5%
Poorly correlated
+5.13%
More